Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Letorise Tablet

Prescription Icon
Prescription Required

Marketer

Wellshark Pharmaceuticals Pvt Ltd

Salt Composition

Letrozole (2.5mg)

Overview Letorise Tablet

Postmenopausal women with breast cancer may find relief with Letorise Tablets. This medication can be a standalone treatment or used alongside other therapies like surgery or radiotherapy. In advanced breast cancer, it helps curb tumor metastasis. Letorise Tablets can be administered with or without food, always adhering to your physician's prescribed dosage and duration for optimal results. Dosage frequency is determined by your specific condition and treatment goals. Your doctor will personalize your regimen to manage symptoms effectively. Continue taking the medication for the entire prescribed period. Common side effects include hot flushes, tiredness, excessive sweating, and elevated cholesterol. Report any concerning or persistent side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Complete disclosure of all other medications is crucial, as interactions can impact Letorise's efficacy. Pregnancy or breastfeeding should also be reported to your doctor. Baseline and ongoing blood tests to monitor vitamin D levels and bone density may be conducted during treatment.

Uses of Letorise Tablet

Managing breast cancer

Major Benefits of Letorise Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letorise Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Letorise Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letorise Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letorise Tablet can be administered with or without food, although consistent timing is recommended.

How Letorise Tablet works:

Letorise tablets function as an aromatase inhibitor, reducing the body's estrogen production—a key female hormone. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letorise Tablet can be taken with alcohol without adverse reactions.

PregnancyPregnancyUNSAFE

Using Letorise Tablets during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in both animals and pregnant humans has revealed substantial adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Using Letorise Tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.

DrivingDrivingUNSAFE

Taking Letorise Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving is discouraged if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can generally use Letorise Tablet without altering the prescribed dosage. However, data on its use in end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Letorise Tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Letorise Tablet :

Should you forget a Letorise Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Letorise Tablet

LabelValue
Chemical Category Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Letorise Tablet

Letorise tablets are used to treat breast cancer in postmenopausal women. This medication is an aromatase inhibitor.
Letorise tablets are anti-estrogens, working by inhibiting the aromatase enzyme, thus reducing estrogen production. Estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Lowering estrogen levels can therefore help prevent cancer growth.
For advanced breast cancer or cancer that has spread, continue Letorise Tablet treatment until tumor progression. Following tamoxifen or surgery, Letorise Tablet should be taken for five years, or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letorise Tablet followed by three years of tamoxifen may be used.
It's safe to take irbesartan and Letorise together, but monitor your blood pressure closely as Letorise may raise it. Consult your doctor if you experience difficulty managing your blood pressure.
While rare, Letorise Tablet may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Letorise Tablet may cause hot flushes, a common side effect resulting from decreased estrogen. These usually lessen as your body adapts, but may persist throughout treatment, subsiding a few months afterward. If hot flushes are severe, consult your doctor for relief.
Letorise Tablet may cause serious side effects, such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions, though these are rare.
Letorise Tablet can weaken bones (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to check for this.
The Ministry of Health and Family Welfare restricts Letorise Tablet use to ovulation induction in women with anovulatory infertility.
Letorise Tablet
177